BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37959685)

  • 1. In Silico Molecular Docking and Dynamics Simulation Analysis of Potential Histone Lysine Methyl Transferase Inhibitors for Managing β-Thalassemia.
    Ravikumar Y; Koonyosying P; Srichairatanakool S; Ponpandian LN; Kumaravelu J; Srichairatanakool S
    Molecules; 2023 Oct; 28(21):. PubMed ID: 37959685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Discovery of Selective Protein Arginine Methyltransferase 5 Inhibitors in the Management of β-Thalassemia through Computational Methods.
    Pokharel B; Ravikumar Y; Rathinavel L; Chewonarin T; Pongpom M; Tipsuwan W; Koonyosying P; Srichairatanakool S
    Molecules; 2024 Jun; 29(11):. PubMed ID: 38893537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel SAR for quinazoline inhibitors of EHMT1 and EHMT2.
    Leenders R; Zijlmans R; van Bree B; van de Sande M; Trivarelli F; Damen E; Wegert A; Müller D; Ehlert JE; Feger D; Heidemann-Dinger C; Kubbutat M; Schächtele C; Lenstra DC; Mecinović J; Müller G
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2516-2524. PubMed ID: 31350126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel quinoline inhibitor for EHMT2/G9a through virtual screening.
    Charles MRC; Mahesh A; Lin SY; Hsieh HP; Dhayalan A; Coumar MS
    Biochimie; 2020 Jan; 168():220-230. PubMed ID: 31756401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Histone Lysine Methyltransferases Are Required for the Establishment and Maintenance of HIV-1 Latency.
    Nguyen K; Das B; Dobrowolski C; Karn J
    mBio; 2017 Feb; 8(1):. PubMed ID: 28246360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Euchromatin histone methyltransferase II (EHMT2) regulates the expression of ras-related GTP binding C (RRAGC) protein.
    Hwang S; Kim S; Kim K; Yeom J; Park S; Kim I
    BMB Rep; 2020 Nov; 53(11):576-581. PubMed ID: 32684241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of ligand and structure-based pharmacophore screening for the identification of novel natural leads against Euchromatic histone lysine methyltransferase 2 (EHMT2/G9a).
    Jana A; Naga R; Saha S; Griñán-Ferré C; Banerjee DR
    J Biomol Struct Dyn; 2024 Apr; 42(7):3535-3562. PubMed ID: 37216299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells.
    Lu Z; Tian Y; Salwen HR; Chlenski A; Godley LA; Raj JU; Yang Q
    Anticancer Drugs; 2013 Jun; 24(5):484-93. PubMed ID: 23466651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.
    Renneville A; Van Galen P; Canver MC; McConkey M; Krill-Burger JM; Dorfman DM; Holson EB; Bernstein BE; Orkin SH; Bauer DE; Ebert BL
    Blood; 2015 Oct; 126(16):1930-9. PubMed ID: 26320100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards the understanding of the activity of G9a inhibitors: an activity landscape and molecular modeling approach.
    López-López E; Rabal O; Oyarzabal J; Medina-Franco JL
    J Comput Aided Mol Des; 2020 Jun; 34(6):659-669. PubMed ID: 32060676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel hit compounds as potential HDAC1 inhibitors: The case of ligand- and structure-based virtual screening.
    Sirous H; Campiani G; Calderone V; Brogi S
    Comput Biol Med; 2021 Oct; 137():104808. PubMed ID: 34478925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico probing and biological evaluation of SETDB1/ESET-targeted novel compounds that reduce tri-methylated histone H3K9 (H3K9me3) level.
    Park I; Hwang YJ; Kim T; Viswanath ANI; Londhe AM; Jung SY; Sim KM; Min SJ; Lee JE; Seong J; Kim YK; No KT; Ryu H; Pae AN
    J Comput Aided Mol Des; 2017 Oct; 31(10):877-889. PubMed ID: 28879500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an
    Majumder R; Mandal M
    J Biomol Struct Dyn; 2022 Feb; 40(2):696-711. PubMed ID: 32897138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BIX-01294 induces autophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production.
    Kim Y; Kim YS; Kim DE; Lee JS; Song JH; Kim HG; Cho DH; Jeong SY; Jin DH; Jang SJ; Seol HS; Suh YA; Lee SJ; Kim CS; Koh JY; Hwang JJ
    Autophagy; 2013 Dec; 9(12):2126-39. PubMed ID: 24322755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel inhibitors of S-adenosyl-L-homocysteine hydrolase via structure-based virtual screening and molecular dynamics simulations.
    Chen C; Zhou XH; Cheng W; Peng YF; Yu QM; Tan XD
    J Mol Model; 2022 Sep; 28(10):336. PubMed ID: 36180796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel histone lysine methyltransferase G9a/GLP (EHMT2/1) inhibitors: Design, synthesis, and structure-activity relationships of 2,4-diamino-6-methylpyrimidines.
    Katayama K; Ishii K; Tsuda E; Yotsumoto K; Hiramoto K; Suzuki M; Yasumatsu I; Igarashi W; Torihata M; Ishiyama T; Katagiri T
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127475. PubMed ID: 32781218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDC1 methylation mediated by lysine methyltransferases EHMT1 and EHMT2 regulates active ATM accumulation flanking DNA damage sites.
    Watanabe S; Iimori M; Chan DV; Hara E; Kitao H; Maehara Y
    Sci Rep; 2018 Jul; 8(1):10888. PubMed ID: 30022091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Euchromatic Histone Lysine Methyltransferase 2 (EHMT2) Suppresses the Proliferation and Invasion of Cervical Cancer Cells.
    Chen G; Yu X; Zhang M; Zheng A; Wang Z; Zuo Y; Liang Q; Jiang D; Chen Y; Zhao L; Jiang L; Li D; Liao S
    Cytogenet Genome Res; 2019; 158(4):205-212. PubMed ID: 31434093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxylic acid derivatives display potential selectivity for human histone deacetylase 6: Structure-based virtual screening, molecular docking and dynamics simulation studies.
    Uba AI; Yelekçi K
    Comput Biol Chem; 2018 Aug; 75():131-142. PubMed ID: 29859380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential patterns of histone methylase EHMT2 and its catalyzed histone modifications H3K9me1 and H3K9me2 during maturation of central auditory system.
    Ebbers L; Runge K; Nothwang HG
    Cell Tissue Res; 2016 Aug; 365(2):247-64. PubMed ID: 27083448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.